NCT03282799View on ClinicalTrials.gov

Pharmacologic Strategies for the Etonogestrel Implant in HIV-Infected Women

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

February 19, 2019

Primary Completion Date

December 22, 2020

Study Completion Date

October 25, 2022

Conditions
HIV/AIDSContraception
Interventions
DRUG

etonogestrel implant

The etonogestrel implant is an contraceptive implant that is placed into the upper arm.

Trial Locations (1)

Unknown

Infectious Disease Institute, Kampala

All Listed Sponsors
collaborator

Infectious Disease Institute, Kampala, Uganda

OTHER

collaborator

University of Nebraska

OTHER

lead

Catherine Anne Chappell

OTHER

NCT03282799 - Pharmacologic Strategies for the Etonogestrel Implant in HIV-Infected Women | Biotech Hunter | Biotech Hunter